Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)


Open article in different language:  DE  |  FR  |  IT
Art. 30 Compulsory testing

1 A sample of every col­lec­ted blood dona­tion used for trans­fu­sion or to man­u­fac­ture labile blood products must be tested in ac­cord­ance with the test­ing re­quire­ments lis­ted in An­nex 5 num­ber 2.

2 The tests must be per­formed us­ing ap­pro­pri­ate meth­ods or pro­ced­ures that are val­id­ated in ac­cord­ance with the state-of-the-art sci­entif­ic and tech­nic­al know­ledge and are suit­able for test­ing donated blood and plasma.

3 Be­fore blood or eryth­ro­cyte pre­par­a­tions are trans­fused, their com­pat­ib­il­ity with the re­cip­i­ent's blood must be es­tab­lished us­ing ap­pro­pri­ate meth­ods.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden